Back
Entrée Resources Ltd. Vs. Amphastar Pharmaceuticals, Inc. Industry Stock Comparison
Sell
30
ERLFF
Entrée Resources Ltd.
Last Price:
$1.62
Seasonality Move:
-0.63%
Sell
35
AMPH
Amphastar Pharmaceuticals, Inc.
Last Price:
$26.33
Seasonality Move:
0.37%
Sell
30
Entrée Resources Ltd. (ERLFF)
is a Sell
Is Entrée Resources Ltd. a Buy, Sell or Hold?
-
The current Entrée Resources Ltd. [ERLFF] share price is $1.67. The Score for ERLFF is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
ERLFF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Amphastar Pharmaceuticals, Inc. (AMPH)
is a Sell
Is Amphastar Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Amphastar Pharmaceuticals, Inc. [AMPH] share price is $25.27. The Score for AMPH is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
AMPH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ERLFF Stock Price Chart
What is Entrée Resources Ltd.'s stock price today?
-
The Entrée Resources Ltd. share price today is $1.67Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ERLFF is experiencing slight selling pressure.
AMPH Stock Price Chart
What is Amphastar Pharmaceuticals, Inc.'s stock price today?
-
The Amphastar Pharmaceuticals, Inc. share price today is $25.27Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AMPH is experiencing selling pressure, which indicates risk of future bearish movement.
ERLFF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 50.29 | Buy |
| Chaikin Money Flow: | -9826 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.62 - 1.7) | Buy |
| Bollinger Bands (100): | (1.55 - 1.71) | Buy |
AMPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 42.93 | Sell |
| Chaikin Money Flow: | -290015 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.46 - 27.32) | Sell |
| Bollinger Bands (100): | (23.69 - 28.87) | Sell |
ERLFF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.69 | Sell |
| 20-day SMA: | 1.66 | Buy |
| 50-day SMA: | 1.66 | Buy |
| 200-day SMA: | 1.61 | Buy |
| 8-day EMA: | 1.68 | Sell |
| 20-day EMA: | 1.67 | Sell |
| 50-day EMA: | 1.63 | Buy |
| 200-day EMA: | 1.1 | Buy |
AMPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.26 | Sell |
| 20-day SMA: | 26.42 | Sell |
| 50-day SMA: | 25.51 | Sell |
| 200-day SMA: | 25.69 | Sell |
| 8-day EMA: | 26.03 | Sell |
| 20-day EMA: | 26.21 | Sell |
| 50-day EMA: | 26.07 | Sell |
| 200-day EMA: | 27.97 | Sell |
Entrée Resources Ltd. Earnings Growth & ERLFF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Amphastar Pharmaceuticals, Inc. Earnings Growth & AMPH Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.51 per share, and an increase next year of $0.29 per share.
Entrée Resources Ltd. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Amphastar Pharmaceuticals, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||